Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab

J Clin Pathol. 2007 Jun;60(6):715-6. doi: 10.1136/jcp.2006.041426. Epub 2007 May 4.

Authors

T M El-Shanawany¹, P E Williams, S Jolles

Affiliation

¹ Department of Immunology, University Hospital of Wales, Cardiff, UK. [email protected]

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20 / immunology
Common Variable Immunodeficiency / complications*
Female
Follow-Up Studies
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunosuppressive Agents / therapeutic use
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Purpura, Thrombocytopenic, Idiopathic / etiology
Rituximab
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
Immunoglobulins, Intravenous
Immunosuppressive Agents
Rituximab